Rank | Gene Set | Z-score |
---|---|---|
1 | viral transcription (GO:0019083) | 5.41513971 |
2 | translational termination (GO:0006415) | 5.18390665 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.18198099 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.17099893 |
5 | negative regulation of cell killing (GO:0031342) | 5.17099893 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.12951891 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.00657933 |
8 | modulation by symbiont of host defense response (GO:0052031) | 5.00657933 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.00657933 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.00657933 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.00657933 |
12 | modulation by symbiont of host immune response (GO:0052553) | 5.00657933 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.92511053 |
14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87650237 |
15 | ribosomal small subunit assembly (GO:0000028) | 4.85241686 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66886249 |
17 | ribosomal small subunit biogenesis (GO:0042274) | 4.57311299 |
18 | translational elongation (GO:0006414) | 4.55832690 |
19 | response to peptidoglycan (GO:0032494) | 4.48091924 |
20 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.38349947 |
21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.35599760 |
22 | detection of bacterium (GO:0016045) | 4.30809524 |
23 | maturation of SSU-rRNA (GO:0030490) | 4.28325646 |
24 | detection of other organism (GO:0098543) | 4.27421000 |
25 | translational initiation (GO:0006413) | 4.19626479 |
26 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.15321989 |
27 | viral life cycle (GO:0019058) | 4.13521333 |
28 | macrophage activation involved in immune response (GO:0002281) | 4.09339885 |
29 | cellular protein complex disassembly (GO:0043624) | 4.03096633 |
30 | DNA unwinding involved in DNA replication (GO:0006268) | 4.02959794 |
31 | protein localization to kinetochore (GO:0034501) | 4.01644582 |
32 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.01229970 |
33 | immunoglobulin mediated immune response (GO:0016064) | 4.00698907 |
34 | leukocyte aggregation (GO:0070486) | 3.99804173 |
35 | NIK/NF-kappaB signaling (GO:0038061) | 3.94257368 |
36 | negative regulation of interleukin-12 production (GO:0032695) | 3.93889895 |
37 | response to muramyl dipeptide (GO:0032495) | 3.92230106 |
38 | protein targeting to ER (GO:0045047) | 3.91679715 |
39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.88502349 |
40 | neutrophil activation involved in immune response (GO:0002283) | 3.88348073 |
41 | cotranslational protein targeting to membrane (GO:0006613) | 3.88148303 |
42 | tolerance induction (GO:0002507) | 3.82909487 |
43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78704181 |
44 | protein complex disassembly (GO:0043241) | 3.77585182 |
45 | cellular response to type I interferon (GO:0071357) | 3.73780505 |
46 | type I interferon signaling pathway (GO:0060337) | 3.73780505 |
47 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.71798306 |
48 | response to type I interferon (GO:0034340) | 3.71247807 |
49 | ribosomal large subunit biogenesis (GO:0042273) | 3.68390431 |
50 | regulation of gene silencing by miRNA (GO:0060964) | 3.65377430 |
51 | regulation of gene silencing by RNA (GO:0060966) | 3.65377430 |
52 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.65377430 |
53 | positive thymic T cell selection (GO:0045059) | 3.65065638 |
54 | protein localization to chromosome, centromeric region (GO:0071459) | 3.61701577 |
55 | protein localization to endoplasmic reticulum (GO:0070972) | 3.58133455 |
56 | germinal center formation (GO:0002467) | 3.57616836 |
57 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.56477734 |
58 | B cell receptor signaling pathway (GO:0050853) | 3.52610189 |
59 | heterochromatin organization (GO:0070828) | 3.51340172 |
60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51057698 |
61 | myeloid dendritic cell differentiation (GO:0043011) | 3.46576559 |
62 | macromolecular complex disassembly (GO:0032984) | 3.45838002 |
63 | trophectodermal cell differentiation (GO:0001829) | 3.44840378 |
64 | detection of external biotic stimulus (GO:0098581) | 3.44824894 |
65 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.41845329 |
66 | dosage compensation (GO:0007549) | 3.41478088 |
67 | formation of translation preinitiation complex (GO:0001731) | 3.39131237 |
68 | response to host immune response (GO:0052572) | 3.37095592 |
69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37095592 |
70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.35783920 |
71 | cellular extravasation (GO:0045123) | 3.35758214 |
72 | regulation of translational fidelity (GO:0006450) | 3.34910332 |
73 | response to interleukin-15 (GO:0070672) | 3.31789618 |
74 | defense response to protozoan (GO:0042832) | 3.30826075 |
75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29267022 |
76 | negative thymic T cell selection (GO:0045060) | 3.24844161 |
77 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.24533049 |
78 | thymic T cell selection (GO:0045061) | 3.22992449 |
79 | T cell migration (GO:0072678) | 3.22788024 |
80 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.22681558 |
81 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.22567163 |
82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.22044583 |
83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.21513466 |
84 | response to host (GO:0075136) | 3.21513466 |
85 | response to host defenses (GO:0052200) | 3.21513466 |
86 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.19510452 |
87 | respiratory burst (GO:0045730) | 3.19402616 |
88 | myeloid dendritic cell activation (GO:0001773) | 3.19188557 |
89 | response to protozoan (GO:0001562) | 3.18367998 |
90 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.17280939 |
91 | DNA replication initiation (GO:0006270) | 3.17143412 |
92 | mitotic sister chromatid segregation (GO:0000070) | 3.17109591 |
93 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16137363 |
94 | regulation of histone H3-K9 methylation (GO:0051570) | 3.12881649 |
95 | mitotic nuclear envelope disassembly (GO:0007077) | 3.12721487 |
96 | positive regulation of B cell differentiation (GO:0045579) | 3.10538673 |
97 | negative regulation of histone methylation (GO:0031061) | 3.10157328 |
98 | mRNA catabolic process (GO:0006402) | 3.09504496 |
99 | negative T cell selection (GO:0043383) | 3.07907556 |
100 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.06853844 |
101 | RNA catabolic process (GO:0006401) | 3.06772707 |
102 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.06722550 |
103 | T cell selection (GO:0045058) | 3.06213760 |
104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06025481 |
105 | DNA strand elongation (GO:0022616) | 3.03906282 |
106 | detection of biotic stimulus (GO:0009595) | 3.02743460 |
107 | B cell mediated immunity (GO:0019724) | 3.02614161 |
108 | sister chromatid segregation (GO:0000819) | 3.02340991 |
109 | regulation of T cell tolerance induction (GO:0002664) | 3.02283578 |
110 | positive T cell selection (GO:0043368) | 3.01919426 |
111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.01490262 |
112 | myeloid cell activation involved in immune response (GO:0002275) | 3.01270590 |
113 | T-helper 1 type immune response (GO:0042088) | 2.99165352 |
114 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.99023830 |
115 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.99023830 |
116 | cellular response to interleukin-15 (GO:0071350) | 2.98478654 |
117 | B cell homeostasis (GO:0001782) | 2.96394592 |
118 | embryonic process involved in female pregnancy (GO:0060136) | 2.96391609 |
119 | regulation of mast cell degranulation (GO:0043304) | 2.95553666 |
120 | neutrophil activation (GO:0042119) | 2.95418137 |
121 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.93578444 |
122 | detection of molecule of bacterial origin (GO:0032490) | 2.93457538 |
123 | granulocyte activation (GO:0036230) | 2.92896002 |
124 | modulation by symbiont of host cellular process (GO:0044068) | 2.92843826 |
125 | mitotic chromosome condensation (GO:0007076) | 2.92039712 |
126 | negative regulation of RNA splicing (GO:0033119) | 2.90064333 |
127 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.90019322 |
128 | membrane disassembly (GO:0030397) | 2.89614816 |
129 | nuclear envelope disassembly (GO:0051081) | 2.89614816 |
130 | regulation of B cell differentiation (GO:0045577) | 2.89218481 |
131 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.87699165 |
132 | nuclear pore organization (GO:0006999) | 2.86346610 |
133 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.85511445 |
134 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.84750790 |
135 | chromatin assembly (GO:0031497) | 2.84546897 |
136 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.83967399 |
137 | negative regulation of phagocytosis (GO:0050765) | 2.83155962 |
138 | modulation by virus of host process (GO:0019054) | 2.82860749 |
139 | regulation of tolerance induction (GO:0002643) | 2.82611480 |
140 | negative regulation of innate immune response (GO:0045824) | 2.81811066 |
141 | DNA duplex unwinding (GO:0032508) | 2.79989401 |
142 | ncRNA 3-end processing (GO:0043628) | 2.79944931 |
143 | interferon-gamma secretion (GO:0072643) | 2.79812536 |
144 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.79799814 |
145 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.78836210 |
146 | DNA geometric change (GO:0032392) | 2.78068826 |
147 | negative regulation of interleukin-6 production (GO:0032715) | 2.77294389 |
148 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76963983 |
149 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.75425929 |
150 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.75425929 |
151 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74332620 |
152 | protein localization to chromosome (GO:0034502) | 2.74078381 |
153 | establishment of apical/basal cell polarity (GO:0035089) | 2.73166296 |
154 | RNA stabilization (GO:0043489) | 2.72900210 |
155 | mRNA stabilization (GO:0048255) | 2.72900210 |
156 | lymphocyte homeostasis (GO:0002260) | 2.72632309 |
157 | apoptotic process involved in morphogenesis (GO:0060561) | 2.72209774 |
158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.70833503 |
159 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.69404312 |
160 | maternal placenta development (GO:0001893) | 2.69365027 |
161 | positive regulation of interferon-alpha production (GO:0032727) | 2.69306839 |
162 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69254809 |
163 | regulation of leukocyte degranulation (GO:0043300) | 2.68869184 |
164 | macrophage activation (GO:0042116) | 2.68605438 |
165 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.68487233 |
166 | nuclear pore complex assembly (GO:0051292) | 2.68022664 |
167 | DNA deamination (GO:0045006) | 2.67580940 |
168 | IMP biosynthetic process (GO:0006188) | 2.67154579 |
169 | positive regulation of chromosome segregation (GO:0051984) | 2.67126226 |
170 | regulation of antigen processing and presentation (GO:0002577) | 2.67082902 |
171 | negative regulation of mRNA processing (GO:0050686) | 2.66218238 |
172 | mitotic metaphase plate congression (GO:0007080) | 2.66091630 |
173 | pre-miRNA processing (GO:0031054) | 2.63942541 |
174 | regulation of helicase activity (GO:0051095) | 2.63847573 |
175 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.63498843 |
176 | protein targeting to membrane (GO:0006612) | 2.56537898 |
177 | regulation of gene silencing (GO:0060968) | 2.56241759 |
178 | negative regulation of mRNA metabolic process (GO:1903312) | 2.55122544 |
179 | T cell apoptotic process (GO:0070231) | 2.54951420 |
180 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.54394777 |
181 | regulation of hippo signaling (GO:0035330) | 2.51846719 |
182 | determination of adult lifespan (GO:0008340) | 2.50880460 |
183 | regulation of sister chromatid cohesion (GO:0007063) | 2.50723061 |
184 | DNA replication checkpoint (GO:0000076) | 2.49124901 |
185 | translation (GO:0006412) | 2.47607495 |
186 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.46610902 |
187 | nucleobase biosynthetic process (GO:0046112) | 2.46101077 |
188 | negative regulation of translational initiation (GO:0045947) | 2.45465749 |
189 | rRNA processing (GO:0006364) | 2.44314937 |
190 | chromatin assembly or disassembly (GO:0006333) | 2.42340992 |
191 | rRNA metabolic process (GO:0016072) | 2.40172241 |
192 | IMP metabolic process (GO:0046040) | 2.39825397 |
193 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.39738604 |
194 | mitotic recombination (GO:0006312) | 2.38721037 |
195 | metaphase plate congression (GO:0051310) | 2.38637304 |
196 | nuclear envelope organization (GO:0006998) | 2.38468661 |
197 | telomere maintenance via recombination (GO:0000722) | 2.38336066 |
198 | regulation of translational termination (GO:0006449) | 2.37744522 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.62345115 |
2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.22306643 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90846201 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18604586 |
5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.04760882 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00946721 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 2.80689280 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70151239 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.68092110 |
10 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.62670571 |
11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.61281818 |
12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59523561 |
13 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.55025742 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.49606525 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.42759844 |
16 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.30027041 |
17 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.23568752 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.23347028 |
19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21049717 |
20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17037584 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12996805 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09473832 |
23 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.09125129 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.07013476 |
25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04647591 |
26 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.04000870 |
27 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.04000870 |
28 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.04000870 |
29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02415456 |
30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.01370285 |
31 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.99641195 |
32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97523096 |
33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.95140414 |
34 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91357659 |
35 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87284012 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.86820305 |
37 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.85321967 |
38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84382772 |
39 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.83361776 |
40 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.79510019 |
41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.74837940 |
42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.74311115 |
43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72808792 |
44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71722663 |
45 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.71524662 |
46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.71443813 |
47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.68053234 |
48 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.65045691 |
49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61927703 |
50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.59690225 |
51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56803618 |
52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56291891 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55555769 |
54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47328574 |
55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.47293134 |
56 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.43384842 |
57 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.41716946 |
58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.40388393 |
59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.39772158 |
60 | MAF_26560356_Chip-Seq_TH1_Human | 1.38570416 |
61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37773333 |
62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37052338 |
63 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37034292 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36961422 |
65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.35905763 |
66 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.34654384 |
67 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34314102 |
68 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32171971 |
69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31635403 |
70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.31400542 |
71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31393184 |
72 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30791682 |
73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.29660851 |
74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.29534522 |
75 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.29479518 |
76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29399499 |
77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29035528 |
78 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28328137 |
79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.28073231 |
80 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27490151 |
81 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.26990991 |
82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26028414 |
83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25759458 |
84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25437500 |
85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25420805 |
86 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.25295953 |
87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.24676174 |
88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22630076 |
89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22247667 |
90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.22204504 |
91 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22106542 |
92 | P68_20966046_ChIP-Seq_HELA_Human | 1.21860734 |
93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21480430 |
94 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.21262340 |
95 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.20241037 |
96 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19606157 |
97 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19315460 |
98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.19311671 |
99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18901183 |
100 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.17404782 |
101 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17373030 |
102 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17139890 |
103 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16500578 |
104 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15592757 |
105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15461001 |
106 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15264130 |
107 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15157439 |
108 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14639228 |
109 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13920681 |
110 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13723898 |
111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13300135 |
112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13045250 |
113 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12500071 |
114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12416659 |
115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12308088 |
116 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12254178 |
117 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12094460 |
118 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.11535967 |
119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10279605 |
120 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10018438 |
121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09312403 |
122 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08529863 |
123 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08439095 |
124 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06945227 |
125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06194394 |
126 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05182501 |
127 | MAF_26560356_Chip-Seq_TH2_Human | 1.05111792 |
128 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04886509 |
129 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03780872 |
130 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03278063 |
131 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03069618 |
132 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02727787 |
133 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02482332 |
134 | MYB_26560356_Chip-Seq_TH2_Human | 1.02321146 |
135 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.02185414 |
136 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.02149961 |
137 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01718592 |
138 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01555976 |
139 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00656857 |
140 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00305168 |
141 | MYB_26560356_Chip-Seq_TH1_Human | 1.00244615 |
142 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00085497 |
143 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.00077385 |
144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.99988474 |
145 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99067919 |
146 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.98979700 |
147 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98757355 |
148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98058685 |
149 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.97667139 |
150 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.97554182 |
151 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97255698 |
152 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97119807 |
153 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97042010 |
154 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96786468 |
155 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96435539 |
156 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94472976 |
157 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.94038556 |
158 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93973900 |
159 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93754427 |
160 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92156428 |
161 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91463699 |
162 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90523348 |
163 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90066148 |
164 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89934325 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.54790934 |
2 | MP0001835_abnormal_antigen_presentation | 3.36730286 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.21319554 |
4 | MP0003724_increased_susceptibility_to | 3.14906307 |
5 | MP0010352_gastrointestinal_tract_polyps | 3.10853475 |
6 | MP0005671_abnormal_response_to | 3.06480811 |
7 | MP0003111_abnormal_nucleus_morphology | 2.88103927 |
8 | MP0002419_abnormal_innate_immunity | 2.66461689 |
9 | MP0003077_abnormal_cell_cycle | 2.66069064 |
10 | MP0009785_altered_susceptibility_to | 2.66028206 |
11 | MP0010094_abnormal_chromosome_stability | 2.59249014 |
12 | MP0002148_abnormal_hypersensitivity_rea | 2.43718108 |
13 | MP0005451_abnormal_body_composition | 2.35231384 |
14 | MP0008057_abnormal_DNA_replication | 2.30924396 |
15 | MP0004510_myositis | 2.21228485 |
16 | MP0005076_abnormal_cell_differentiation | 2.19753019 |
17 | MP0000490_abnormal_crypts_of | 2.15073356 |
18 | MP0003705_abnormal_hypodermis_morpholog | 2.14921459 |
19 | MP0010234_abnormal_vibrissa_follicle | 2.08288678 |
20 | MP0006082_CNS_inflammation | 2.01615075 |
21 | MP0003300_gastrointestinal_ulcer | 1.96314305 |
22 | MP0003763_abnormal_thymus_physiology | 1.91367148 |
23 | MP0001730_embryonic_growth_arrest | 1.88148856 |
24 | MP0009278_abnormal_bone_marrow | 1.86413793 |
25 | MP0001533_abnormal_skeleton_physiology | 1.85460050 |
26 | MP0000350_abnormal_cell_proliferation | 1.84748330 |
27 | MP0005464_abnormal_platelet_physiology | 1.78336997 |
28 | MP0008260_abnormal_autophagy | 1.77799309 |
29 | MP0010307_abnormal_tumor_latency | 1.77551870 |
30 | MP0001845_abnormal_inflammatory_respons | 1.72096777 |
31 | MP0008007_abnormal_cellular_replicative | 1.67274639 |
32 | MP0005058_abnormal_lysosome_morphology | 1.61592595 |
33 | MP0003191_abnormal_cellular_cholesterol | 1.60731656 |
34 | MP0002086_abnormal_extraembryonic_tissu | 1.56484709 |
35 | MP0002396_abnormal_hematopoietic_system | 1.56353404 |
36 | MP0003566_abnormal_cell_adhesion | 1.55518050 |
37 | MP0009333_abnormal_splenocyte_physiolog | 1.54567930 |
38 | MP0005310_abnormal_salivary_gland | 1.54349207 |
39 | MP0005501_abnormal_skin_physiology | 1.52074271 |
40 | MP0003453_abnormal_keratinocyte_physiol | 1.51348493 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.49840240 |
42 | MP0001545_abnormal_hematopoietic_system | 1.49840240 |
43 | MP0010155_abnormal_intestine_physiology | 1.49345262 |
44 | MP0000685_abnormal_immune_system | 1.49068075 |
45 | MP0001853_heart_inflammation | 1.45950787 |
46 | MP0001697_abnormal_embryo_size | 1.45451393 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.44609160 |
48 | MP0005380_embryogenesis_phenotype | 1.44227074 |
49 | MP0001672_abnormal_embryogenesis/_devel | 1.44227074 |
50 | MP0003172_abnormal_lysosome_physiology | 1.41529961 |
51 | MP0004264_abnormal_extraembryonic_tissu | 1.40684172 |
52 | MP0000703_abnormal_thymus_morphology | 1.39829930 |
53 | MP0002398_abnormal_bone_marrow | 1.38651217 |
54 | MP0002084_abnormal_developmental_patter | 1.37532507 |
55 | MP0004197_abnormal_fetal_growth/weight/ | 1.37351238 |
56 | MP0002085_abnormal_embryonic_tissue | 1.37129876 |
57 | MP0008469_abnormal_protein_level | 1.37050451 |
58 | MP0001849_ear_inflammation | 1.36570119 |
59 | MP0002019_abnormal_tumor_incidence | 1.35956246 |
60 | MP0008932_abnormal_embryonic_tissue | 1.35490337 |
61 | MP0002088_abnormal_embryonic_growth/wei | 1.35431716 |
62 | MP0004808_abnormal_hematopoietic_stem | 1.35425955 |
63 | MP0003866_abnormal_defecation | 1.35324591 |
64 | MP0002796_impaired_skin_barrier | 1.35207805 |
65 | MP0003984_embryonic_growth_retardation | 1.34749789 |
66 | MP0008058_abnormal_DNA_repair | 1.34581301 |
67 | MP0003303_peritoneal_inflammation | 1.32843991 |
68 | MP0002080_prenatal_lethality | 1.31425302 |
69 | MP0002722_abnormal_immune_system | 1.31269376 |
70 | MP0003567_abnormal_fetal_cardiomyocyte | 1.31094464 |
71 | MP0009764_decreased_sensitivity_to | 1.28379563 |
72 | MP0000537_abnormal_urethra_morphology | 1.27728571 |
73 | MP0002653_abnormal_ependyma_morphology | 1.26171137 |
74 | MP0003436_decreased_susceptibility_to | 1.26024789 |
75 | MP0002998_abnormal_bone_remodeling | 1.25624290 |
76 | MP0000858_altered_metastatic_potential | 1.24527540 |
77 | MP0000477_abnormal_intestine_morphology | 1.22806761 |
78 | MP0002166_altered_tumor_susceptibility | 1.20889257 |
79 | MP0001851_eye_inflammation | 1.20712552 |
80 | MP0003183_abnormal_peptide_metabolism | 1.20642298 |
81 | MP0000689_abnormal_spleen_morphology | 1.20422355 |
82 | MP0000313_abnormal_cell_death | 1.18388843 |
83 | MP0002405_respiratory_system_inflammati | 1.17604105 |
84 | MP0005023_abnormal_wound_healing | 1.17112557 |
85 | MP0002132_abnormal_respiratory_system | 1.17057094 |
86 | MP0004947_skin_inflammation | 1.16769492 |
87 | MP0001800_abnormal_humoral_immune | 1.14748650 |
88 | MP0002277_abnormal_respiratory_mucosa | 1.12578496 |
89 | MP0009053_abnormal_anal_canal | 1.11148643 |
90 | MP0003075_altered_response_to | 1.11095056 |
91 | MP0003119_abnormal_digestive_system | 1.07628307 |
92 | MP0002429_abnormal_blood_cell | 1.07577891 |
93 | MP0000343_altered_response_to | 1.07275464 |
94 | MP0003786_premature_aging | 1.06536212 |
95 | MP0001663_abnormal_digestive_system | 1.04774049 |
96 | MP0001216_abnormal_epidermal_layer | 1.04245120 |
97 | MP0004381_abnormal_hair_follicle | 1.04080517 |
98 | MP0002006_tumorigenesis | 1.02512661 |
99 | MP0000716_abnormal_immune_system | 1.01394423 |
100 | MP0005166_decreased_susceptibility_to | 1.00907468 |
101 | MP0004185_abnormal_adipocyte_glucose | 0.99686381 |
102 | MP0001873_stomach_inflammation | 0.99192231 |
103 | MP0003656_abnormal_erythrocyte_physiolo | 0.97954281 |
104 | MP0002009_preneoplasia | 0.97300045 |
105 | MP0000465_gastrointestinal_hemorrhage | 0.95793040 |
106 | MP0002420_abnormal_adaptive_immunity | 0.94651687 |
107 | MP0003941_abnormal_skin_development | 0.94425645 |
108 | MP0001819_abnormal_immune_cell | 0.93822483 |
109 | MP0002877_abnormal_melanocyte_morpholog | 0.92403877 |
110 | MP0002452_abnormal_antigen_presenting | 0.90388998 |
111 | MP0002933_joint_inflammation | 0.90308011 |
112 | MP0003448_altered_tumor_morphology | 0.88300421 |
113 | MP0010030_abnormal_orbit_morphology | 0.88278149 |
114 | MP0003091_abnormal_cell_migration | 0.87357056 |
115 | MP0001790_abnormal_immune_system | 0.87115507 |
116 | MP0005387_immune_system_phenotype | 0.87115507 |
117 | MP0002098_abnormal_vibrissa_morphology | 0.85532249 |
118 | MP0003123_paternal_imprinting | 0.85445257 |
119 | MP0009931_abnormal_skin_appearance | 0.85114048 |
120 | MP0000604_amyloidosis | 0.84129656 |
121 | MP0005390_skeleton_phenotype | 0.83595168 |
122 | MP0002723_abnormal_immune_serum | 0.83320025 |
123 | MP0003806_abnormal_nucleotide_metabolis | 0.82762625 |
124 | MP0000377_abnormal_hair_follicle | 0.79625291 |
125 | MP0000733_abnormal_muscle_development | 0.78064596 |
126 | MP0005025_abnormal_response_to | 0.76656089 |
127 | MP0009840_abnormal_foam_cell | 0.76487462 |
128 | MP0001915_intracranial_hemorrhage | 0.75680012 |
129 | MP0005000_abnormal_immune_tolerance | 0.75628333 |
130 | MP0009763_increased_sensitivity_to | 0.75253572 |
131 | MP0004883_abnormal_blood_vessel | 0.75147112 |
132 | MP0001293_anophthalmia | 0.74596116 |
133 | MP0003045_fibrosis | 0.74356309 |
134 | MP0002925_abnormal_cardiovascular_devel | 0.74012959 |
135 | MP0002060_abnormal_skin_morphology | 0.73676721 |
136 | MP0008004_abnormal_stomach_pH | 0.70748220 |
137 | MP0000467_abnormal_esophagus_morphology | 0.69192332 |
138 | MP0002111_abnormal_tail_morphology | 0.68607882 |
139 | MP0009765_abnormal_xenobiotic_induced | 0.67724004 |
140 | MP0005666_abnormal_adipose_tissue | 0.67678485 |
141 | MP0003828_pulmonary_edema | 0.67260814 |
142 | MP0000249_abnormal_blood_vessel | 0.66720200 |
143 | MP0005381_digestive/alimentary_phenotyp | 0.65340708 |
144 | MP0005164_abnormal_response_to | 0.64434746 |
145 | MP0001348_abnormal_lacrimal_gland | 0.62077267 |
146 | MP0008874_decreased_physiological_sensi | 0.61409611 |
147 | MP0003795_abnormal_bone_structure | 0.60675818 |
148 | MP0004858_abnormal_nervous_system | 0.60639819 |
149 | MP0000678_abnormal_parathyroid_gland | 0.57174489 |
150 | MP0000609_abnormal_liver_physiology | 0.53639251 |
151 | MP0009115_abnormal_fat_cell | 0.49301216 |
152 | MP0002693_abnormal_pancreas_physiology | 0.48043531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.94218191 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.91482530 |
3 | Recurrent abscess formation (HP:0002722) | 4.80585391 |
4 | Abnormality of macrophages (HP:0004311) | 4.68490944 |
5 | Reticulocytopenia (HP:0001896) | 4.65974697 |
6 | Myositis (HP:0100614) | 4.45066900 |
7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.31143237 |
8 | Orchitis (HP:0100796) | 4.11758757 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.08208930 |
10 | Meningitis (HP:0001287) | 4.07745683 |
11 | Obstructive lung disease (HP:0006536) | 3.98272213 |
12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.98272213 |
13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.97986577 |
14 | Gastrointestinal stroma tumor (HP:0100723) | 3.92541660 |
15 | Retrobulbar optic neuritis (HP:0100654) | 3.81379883 |
16 | Optic neuritis (HP:0100653) | 3.81379883 |
17 | Stomatitis (HP:0010280) | 3.76744099 |
18 | Abnormal number of erythroid precursors (HP:0012131) | 3.75542936 |
19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73843495 |
20 | Vasculitis (HP:0002633) | 3.73751597 |
21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.62280997 |
22 | Ependymoma (HP:0002888) | 3.46312757 |
23 | Gastrointestinal infarctions (HP:0005244) | 3.43378452 |
24 | Recurrent skin infections (HP:0001581) | 3.28484656 |
25 | Urticaria (HP:0001025) | 3.23971479 |
26 | Spontaneous hematomas (HP:0007420) | 3.18583543 |
27 | Encephalitis (HP:0002383) | 3.14367338 |
28 | Lymphopenia (HP:0001888) | 3.09970861 |
29 | Basal cell carcinoma (HP:0002671) | 3.09863383 |
30 | Macrocytic anemia (HP:0001972) | 3.03912761 |
31 | Agammaglobulinemia (HP:0004432) | 3.03474054 |
32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.96887086 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.96887086 |
34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.94178426 |
35 | Increased IgM level (HP:0003496) | 2.92925111 |
36 | Pallor (HP:0000980) | 2.90449780 |
37 | Abnormality of reticulocytes (HP:0004312) | 2.90109206 |
38 | Panhypogammaglobulinemia (HP:0003139) | 2.85696026 |
39 | Colitis (HP:0002583) | 2.83955391 |
40 | Selective tooth agenesis (HP:0001592) | 2.80145125 |
41 | Gingivitis (HP:0000230) | 2.77120560 |
42 | Pulmonary infiltrates (HP:0002113) | 2.73973953 |
43 | Prolonged bleeding time (HP:0003010) | 2.73490403 |
44 | Keratoconjunctivitis sicca (HP:0001097) | 2.71372840 |
45 | Multiple enchondromatosis (HP:0005701) | 2.67081978 |
46 | Emphysema (HP:0002097) | 2.67042609 |
47 | Recurrent sinusitis (HP:0011108) | 2.66823344 |
48 | Pustule (HP:0200039) | 2.63575750 |
49 | Trismus (HP:0000211) | 2.60861671 |
50 | Proximal placement of thumb (HP:0009623) | 2.60708382 |
51 | Absent thumb (HP:0009777) | 2.57421679 |
52 | Hypochromic microcytic anemia (HP:0004840) | 2.56816045 |
53 | Abnormality of T cell physiology (HP:0011840) | 2.55815001 |
54 | Chest pain (HP:0100749) | 2.53767433 |
55 | Purpura (HP:0000979) | 2.53530624 |
56 | Osteomyelitis (HP:0002754) | 2.51504875 |
57 | Colon cancer (HP:0003003) | 2.49502432 |
58 | Deviation of the thumb (HP:0009603) | 2.49404692 |
59 | Restrictive lung disease (HP:0002091) | 2.47052194 |
60 | IgM deficiency (HP:0002850) | 2.45911955 |
61 | Biliary tract neoplasm (HP:0100574) | 2.45888833 |
62 | Hemoptysis (HP:0002105) | 2.44099253 |
63 | Hypergammaglobulinemia (HP:0010702) | 2.42936663 |
64 | Breast hypoplasia (HP:0003187) | 2.42883205 |
65 | Recurrent bronchitis (HP:0002837) | 2.42744838 |
66 | Keratoconjunctivitis (HP:0001096) | 2.38239899 |
67 | Hypertensive crisis (HP:0100735) | 2.37395633 |
68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32949118 |
69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32949118 |
70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32949118 |
71 | Missing ribs (HP:0000921) | 2.32908810 |
72 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.32661830 |
73 | Epistaxis (HP:0000421) | 2.31040346 |
74 | Sepsis (HP:0100806) | 2.30551479 |
75 | Granulocytopenia (HP:0001913) | 2.29466311 |
76 | Patellar aplasia (HP:0006443) | 2.27471740 |
77 | Thrombocytosis (HP:0001894) | 2.26619367 |
78 | Medulloblastoma (HP:0002885) | 2.26042073 |
79 | Rhabdomyosarcoma (HP:0002859) | 2.25497425 |
80 | Oral leukoplakia (HP:0002745) | 2.16622102 |
81 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16423864 |
82 | Rib fusion (HP:0000902) | 2.16383116 |
83 | Autoimmune hemolytic anemia (HP:0001890) | 2.16313983 |
84 | Esophageal atresia (HP:0002032) | 2.14859066 |
85 | Pili torti (HP:0003777) | 2.14714784 |
86 | Arterial thrombosis (HP:0004420) | 2.14518901 |
87 | Increased serum ferritin (HP:0003281) | 2.14442260 |
88 | Abnormal number of incisors (HP:0011064) | 2.14344096 |
89 | Microcytic anemia (HP:0001935) | 2.14081154 |
90 | Autoimmune thrombocytopenia (HP:0001973) | 2.12416326 |
91 | Angiofibromas (HP:0010615) | 2.11995131 |
92 | Adenoma sebaceum (HP:0009720) | 2.11995131 |
93 | Abnormality of T cell number (HP:0011839) | 2.11433828 |
94 | Absent radius (HP:0003974) | 2.11354210 |
95 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.11194866 |
96 | Gastrointestinal carcinoma (HP:0002672) | 2.11194866 |
97 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.10781298 |
98 | Neoplasm of the pancreas (HP:0002894) | 2.10656343 |
99 | Astrocytoma (HP:0009592) | 2.08824725 |
100 | Abnormality of the astrocytes (HP:0100707) | 2.08824725 |
101 | Abnormal hemoglobin (HP:0011902) | 2.08139196 |
102 | Anorexia (HP:0002039) | 2.07643635 |
103 | Polygenic inheritance (HP:0010982) | 2.07457907 |
104 | Leukocytosis (HP:0001974) | 2.07016677 |
105 | Pulmonary embolism (HP:0002204) | 2.06896287 |
106 | Recurrent pneumonia (HP:0006532) | 2.06510516 |
107 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05640389 |
108 | Vertebral clefting (HP:0008428) | 2.05535108 |
109 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.04577724 |
110 | Increased density of long bones (HP:0006392) | 2.04336615 |
111 | Episodic fever (HP:0001954) | 2.04183862 |
112 | Skin ulcer (HP:0200042) | 2.03509137 |
113 | Abnormality of the pleura (HP:0002103) | 2.03340961 |
114 | Nasal polyposis (HP:0100582) | 2.03190627 |
115 | Combined immunodeficiency (HP:0005387) | 2.03005893 |
116 | Poikiloderma (HP:0001029) | 2.01022497 |
117 | Skin rash (HP:0000988) | 2.00294577 |
118 | Gangrene (HP:0100758) | 1.99655342 |
119 | Viral hepatitis (HP:0006562) | 1.99316305 |
120 | Rectal prolapse (HP:0002035) | 1.99165026 |
121 | Abnormality of the fingertips (HP:0001211) | 1.98061669 |
122 | Premature loss of primary teeth (HP:0006323) | 1.97770796 |
123 | Absent forearm bone (HP:0003953) | 1.97393918 |
124 | Aplasia involving forearm bones (HP:0009822) | 1.97393918 |
125 | Carpal bone hypoplasia (HP:0001498) | 1.96396832 |
126 | Woolly hair (HP:0002224) | 1.95923504 |
127 | Arthralgia (HP:0002829) | 1.95518777 |
128 | Slow saccadic eye movements (HP:0000514) | 1.93872910 |
129 | Abnormality of the peritoneum (HP:0002585) | 1.92791370 |
130 | Polycythemia (HP:0001901) | 1.92596183 |
131 | Neoplasm of striated muscle (HP:0009728) | 1.92552269 |
132 | Atresia of the external auditory canal (HP:0000413) | 1.92142454 |
133 | Agnosia (HP:0010524) | 1.91962416 |
134 | Birth length less than 3rd percentile (HP:0003561) | 1.91587591 |
135 | Abnormality of the nasal mucosa (HP:0000433) | 1.91226297 |
136 | Reticulocytosis (HP:0001923) | 1.91184868 |
137 | Hepatosplenomegaly (HP:0001433) | 1.91056711 |
138 | Interstitial pulmonary disease (HP:0006530) | 1.90572054 |
139 | Hypochromic anemia (HP:0001931) | 1.89319288 |
140 | Amaurosis fugax (HP:0100576) | 1.88169592 |
141 | Increased cerebral lipofuscin (HP:0011813) | 1.87730206 |
142 | Gingival bleeding (HP:0000225) | 1.87232250 |
143 | 11 pairs of ribs (HP:0000878) | 1.87125830 |
144 | Squamous cell carcinoma (HP:0002860) | 1.86703914 |
145 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.82671609 |
146 | Increased IgE level (HP:0003212) | 1.81412906 |
147 | Abnormality of T cells (HP:0002843) | 1.81342930 |
148 | Gastrointestinal inflammation (HP:0004386) | 1.79543345 |
149 | Lymphoma (HP:0002665) | 1.78863662 |
150 | Increased nuchal translucency (HP:0010880) | 1.78278876 |
151 | Neoplasm of the oral cavity (HP:0100649) | 1.77733753 |
152 | Degeneration of anterior horn cells (HP:0002398) | 1.77522038 |
153 | Abnormality of the anterior horn cell (HP:0006802) | 1.77522038 |
154 | Chromsome breakage (HP:0040012) | 1.77324641 |
155 | Blepharitis (HP:0000498) | 1.76096302 |
156 | Papilloma (HP:0012740) | 1.75901721 |
157 | Verrucae (HP:0200043) | 1.75901721 |
158 | Skin tags (HP:0010609) | 1.75621931 |
159 | Myelodysplasia (HP:0002863) | 1.74820631 |
160 | Petechiae (HP:0000967) | 1.74374508 |
161 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.72740801 |
162 | Impulsivity (HP:0100710) | 1.72691450 |
163 | Supernumerary ribs (HP:0005815) | 1.72046391 |
164 | Asplenia (HP:0001746) | 1.70789950 |
165 | Prominent nose (HP:0000448) | 1.69753650 |
166 | Preauricular skin tag (HP:0000384) | 1.69492366 |
167 | T lymphocytopenia (HP:0005403) | 1.68995051 |
168 | Recurrent fungal infections (HP:0002841) | 1.68669106 |
169 | Pseudobulbar signs (HP:0002200) | 1.66869373 |
170 | Volvulus (HP:0002580) | 1.66316616 |
171 | Overlapping toe (HP:0001845) | 1.66097364 |
172 | Premature ovarian failure (HP:0008209) | 1.65393805 |
173 | Ulnar bowing (HP:0003031) | 1.65380989 |
174 | Abnormal hair laboratory examination (HP:0003328) | 1.65316039 |
175 | Short humerus (HP:0005792) | 1.65227685 |
176 | Cellulitis (HP:0100658) | 1.64950327 |
177 | Inflammation of the large intestine (HP:0002037) | 1.64727147 |
178 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.64716149 |
179 | Recurrent viral infections (HP:0004429) | 1.64149752 |
180 | Uterine neoplasm (HP:0010784) | 1.63254869 |
181 | Tracheoesophageal fistula (HP:0002575) | 1.63218059 |
182 | Stenosis of the external auditory canal (HP:0000402) | 1.63202094 |
183 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.63002219 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRPF4B | 3.88355111 |
2 | RIPK4 | 3.84668628 |
3 | EEF2K | 3.49215911 |
4 | MAP3K10 | 3.17610569 |
5 | IRAK4 | 3.09246418 |
6 | CDK12 | 3.05245776 |
7 | MAP4K1 | 2.63028726 |
8 | NEK2 | 2.60580607 |
9 | PKN2 | 2.60505218 |
10 | STK10 | 2.47860674 |
11 | RPS6KB2 | 2.43633643 |
12 | EPHA2 | 2.31794617 |
13 | TRIB3 | 2.18315512 |
14 | WEE1 | 2.13980944 |
15 | CDC7 | 2.09161671 |
16 | SMG1 | 2.05963244 |
17 | TLK1 | 2.02720116 |
18 | GRK6 | 2.02368229 |
19 | SIK3 | 1.93236700 |
20 | NME2 | 1.93173041 |
21 | SIK1 | 1.88340091 |
22 | MAP3K14 | 1.87231729 |
23 | IRAK3 | 1.86149791 |
24 | MST4 | 1.78467016 |
25 | TAOK2 | 1.75828892 |
26 | LRRK2 | 1.74614756 |
27 | SIK2 | 1.70831514 |
28 | BUB1 | 1.69022541 |
29 | IKBKE | 1.67254466 |
30 | CDK4 | 1.66037528 |
31 | MAP3K13 | 1.65786856 |
32 | MAP3K8 | 1.57026198 |
33 | TNK2 | 1.52400991 |
34 | FES | 1.50843217 |
35 | PIM1 | 1.49215519 |
36 | TTK | 1.48190140 |
37 | DYRK3 | 1.46417614 |
38 | MAPKAPK3 | 1.40630115 |
39 | CDK7 | 1.38421865 |
40 | SYK | 1.32547629 |
41 | MAP3K1 | 1.31242481 |
42 | MAP2K2 | 1.31130712 |
43 | RPS6KA4 | 1.26181494 |
44 | PAK4 | 1.23676195 |
45 | NEK1 | 1.22701827 |
46 | CDK6 | 1.22500805 |
47 | TXK | 1.22158073 |
48 | STK4 | 1.21627244 |
49 | ERN1 | 1.20674745 |
50 | TESK2 | 1.18590279 |
51 | AURKB | 1.18506682 |
52 | MAP3K11 | 1.16334227 |
53 | ICK | 1.15732740 |
54 | TSSK6 | 1.14752148 |
55 | PASK | 1.12684506 |
56 | PTK6 | 1.11056995 |
57 | HIPK2 | 1.07750750 |
58 | MARK2 | 1.06923873 |
59 | FLT3 | 1.06498399 |
60 | IRAK2 | 1.04607547 |
61 | BRD4 | 1.03088037 |
62 | PLK1 | 1.02262598 |
63 | EIF2AK1 | 1.01500988 |
64 | LYN | 1.00792248 |
65 | ALK | 0.98520275 |
66 | JAK1 | 0.95010419 |
67 | CSF1R | 0.94730839 |
68 | IRAK1 | 0.92878076 |
69 | FGR | 0.91662839 |
70 | BMX | 0.91138337 |
71 | PRKD2 | 0.91098278 |
72 | MAP2K3 | 0.91015347 |
73 | SCYL2 | 0.90095581 |
74 | TGFBR1 | 0.88817247 |
75 | KSR2 | 0.86950935 |
76 | CDC42BPA | 0.86445693 |
77 | JAK2 | 0.85661068 |
78 | LCK | 0.84862229 |
79 | ZAP70 | 0.83652394 |
80 | CSK | 0.83459679 |
81 | KIT | 0.82347229 |
82 | DYRK1B | 0.81393055 |
83 | MAPK12 | 0.81265451 |
84 | CHEK2 | 0.81138412 |
85 | AURKA | 0.80199442 |
86 | ITK | 0.79825641 |
87 | CHEK1 | 0.79333140 |
88 | ATR | 0.78301317 |
89 | BTK | 0.78248209 |
90 | FGFR4 | 0.77229031 |
91 | PDK1 | 0.75796795 |
92 | MTOR | 0.75613227 |
93 | PDPK1 | 0.74806569 |
94 | CLK1 | 0.72469885 |
95 | MAP3K3 | 0.71305406 |
96 | TAOK3 | 0.68104975 |
97 | ACVR1B | 0.67546797 |
98 | BRAF | 0.66017401 |
99 | DMPK | 0.65698011 |
100 | TYK2 | 0.64911429 |
101 | KDR | 0.64809728 |
102 | JAK3 | 0.64797276 |
103 | CHUK | 0.63727396 |
104 | RPS6KA5 | 0.63548840 |
105 | ILK | 0.62781652 |
106 | MAPK7 | 0.61644834 |
107 | PRKCI | 0.61458343 |
108 | MAP3K7 | 0.60646032 |
109 | BLK | 0.60441923 |
110 | MAPK11 | 0.59448716 |
111 | CDK2 | 0.59206908 |
112 | SRPK1 | 0.59175093 |
113 | TAOK1 | 0.58797729 |
114 | VRK1 | 0.58727040 |
115 | RPS6KA1 | 0.58542220 |
116 | RIPK1 | 0.58261871 |
117 | CAMKK1 | 0.56167164 |
118 | MELK | 0.55936632 |
119 | TEC | 0.54754192 |
120 | ARAF | 0.54467850 |
121 | MOS | 0.52944975 |
122 | EPHB2 | 0.52461940 |
123 | STK3 | 0.52263495 |
124 | IKBKB | 0.51911952 |
125 | PIM2 | 0.51299155 |
126 | EPHB1 | 0.51011958 |
127 | BRSK2 | 0.50412470 |
128 | FGFR3 | 0.50306562 |
129 | BMPR2 | 0.50014370 |
130 | PAK1 | 0.49203969 |
131 | AKT2 | 0.47870656 |
132 | TBK1 | 0.47766245 |
133 | MATK | 0.47612470 |
134 | TGFBR2 | 0.47295488 |
135 | ATM | 0.47197662 |
136 | TYRO3 | 0.45348430 |
137 | MAPKAPK2 | 0.45296946 |
138 | RPS6KL1 | 0.45082289 |
139 | RPS6KC1 | 0.45082289 |
140 | PRKCQ | 0.44557650 |
141 | TTN | 0.44516425 |
142 | SGK3 | 0.43983723 |
143 | MARK3 | 0.42014601 |
144 | RPS6KA6 | 0.41857646 |
145 | HCK | 0.41234107 |
146 | MAPK4 | 0.39410380 |
147 | YES1 | 0.36287182 |
148 | CDK19 | 0.34463461 |
149 | PRKCH | 0.32406417 |
150 | RPS6KA2 | 0.32285510 |
151 | FYN | 0.32108436 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.09468848 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.72058333 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 3.27705853 |
4 | Spliceosome_Homo sapiens_hsa03040 | 2.82288600 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.66565673 |
6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.44931558 |
7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.43116918 |
8 | RNA transport_Homo sapiens_hsa03013 | 2.33871753 |
9 | Base excision repair_Homo sapiens_hsa03410 | 2.33702966 |
10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.16848304 |
11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.15604519 |
12 | Cell cycle_Homo sapiens_hsa04110 | 2.15359125 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.12036975 |
14 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.08800662 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 1.85320233 |
16 | Homologous recombination_Homo sapiens_hsa03440 | 1.83908365 |
17 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.83359558 |
18 | Asthma_Homo sapiens_hsa05310 | 1.82928863 |
19 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.81686786 |
20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.77156552 |
21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.70041989 |
22 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.67058555 |
23 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.63619596 |
24 | Malaria_Homo sapiens_hsa05144 | 1.61857720 |
25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52782473 |
26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.48812468 |
27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43057677 |
28 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.40258837 |
29 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39532715 |
30 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39510395 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.35629397 |
32 | RNA polymerase_Homo sapiens_hsa03020 | 1.35475394 |
33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.30534229 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28175865 |
35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27378483 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26694929 |
37 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25707742 |
38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25440362 |
39 | Sulfur relay system_Homo sapiens_hsa04122 | 1.24145833 |
40 | Hepatitis C_Homo sapiens_hsa05160 | 1.19594592 |
41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19252936 |
42 | Bladder cancer_Homo sapiens_hsa05219 | 1.16498300 |
43 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.16056486 |
44 | HTLV-I infection_Homo sapiens_hsa05166 | 1.15208994 |
45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.14864986 |
46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.11039542 |
47 | RNA degradation_Homo sapiens_hsa03018 | 1.10655772 |
48 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10160056 |
49 | Thyroid cancer_Homo sapiens_hsa05216 | 1.09307432 |
50 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05166319 |
51 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04202454 |
52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03696368 |
53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03632698 |
54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03316459 |
55 | Apoptosis_Homo sapiens_hsa04210 | 1.01771815 |
56 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00393416 |
57 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.98763604 |
58 | Salmonella infection_Homo sapiens_hsa05132 | 0.98224884 |
59 | Phagosome_Homo sapiens_hsa04145 | 0.97672943 |
60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97438230 |
61 | Measles_Homo sapiens_hsa05162 | 0.97335910 |
62 | Adherens junction_Homo sapiens_hsa04520 | 0.96880342 |
63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94993950 |
64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93758210 |
65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93421281 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.92418318 |
67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91322356 |
68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89639906 |
69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86038761 |
70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85927175 |
71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.83870876 |
72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.81678361 |
73 | Hepatitis B_Homo sapiens_hsa05161 | 0.80505894 |
74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80136804 |
75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80062625 |
76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79645898 |
77 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.78244326 |
78 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.78161069 |
79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77258346 |
80 | Shigellosis_Homo sapiens_hsa05131 | 0.76403133 |
81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75942111 |
82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72751059 |
83 | Legionellosis_Homo sapiens_hsa05134 | 0.71887893 |
84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71821438 |
85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71778280 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71383496 |
87 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71229228 |
88 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71013784 |
89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68842105 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68782576 |
91 | Platelet activation_Homo sapiens_hsa04611 | 0.68639923 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68599110 |
93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68589418 |
94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.67606249 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.67488329 |
96 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67066602 |
97 | Lysine degradation_Homo sapiens_hsa00310 | 0.67059642 |
98 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65781438 |
99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65764725 |
100 | Lysosome_Homo sapiens_hsa04142 | 0.65068221 |
101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63708470 |
102 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63534524 |
103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63158080 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.62446980 |
105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62397321 |
106 | Endocytosis_Homo sapiens_hsa04144 | 0.62329387 |
107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62146269 |
108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.61335525 |
109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.60309224 |
110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60135593 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59893877 |
112 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59245721 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58797873 |
114 | Proteasome_Homo sapiens_hsa03050 | 0.58333281 |
115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56921112 |
116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56766689 |
117 | Influenza A_Homo sapiens_hsa05164 | 0.56743521 |
118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56483517 |
119 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55877151 |
120 | Tight junction_Homo sapiens_hsa04530 | 0.55500955 |
121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55393105 |
122 | Prostate cancer_Homo sapiens_hsa05215 | 0.55034208 |
123 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54785417 |
124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54097795 |
125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52831352 |
126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52769910 |
127 | Alcoholism_Homo sapiens_hsa05034 | 0.51974616 |
128 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51904650 |
129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50862560 |
130 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50680500 |
131 | Insulin resistance_Homo sapiens_hsa04931 | 0.49743478 |
132 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48800066 |
133 | Amoebiasis_Homo sapiens_hsa05146 | 0.48516512 |
134 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.48177384 |
135 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47644780 |
136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.47055948 |
137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46756496 |
138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43174738 |
139 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42772093 |
140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42235213 |
141 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42209612 |
142 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42204449 |
143 | Glioma_Homo sapiens_hsa05214 | 0.42120075 |
144 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41400096 |
145 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36754183 |
146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36720552 |
147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33244488 |
148 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32976450 |